UPDATED May 09, 2024
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GOOGL | US$169.96 | 2.0% | 45.8% | US$2.1t | US$191.48 | PE25.5x | E12.2% | 0.5% | Media | ||
AMZN | US$189.50 | 2.6% | 68.9% | US$2.0t | US$217.51 | PE52.3x | E21.5% | n/a | Retail | ||
2330 | NT$796.00 | 3.1% | 59.5% | NT$20.6t | NT$915.41 | PE24.1x | E16.1% | 1.8% | Semiconductors | ||
NOVO B | kr.883.20 | 1.2% | 52.9% | kr.3.9t | kr.908.65 | PE44.1x | E13.4% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$197.50 | 3.0% | 45.2% | US$561.8b | US$207.83 | PB1.8x | E-1.3% | 2.3% | Banks | ||
WMT | US$60.44 | 1.2% | 18.4% | US$486.0b | US$65.42 | PE31.4x | E10.8% | 1.4% | Consumer Retailing | ||
700 | HK$369.80 | 2.6% | 13.3% | HK$3.4t | HK$419.57 | PE27.6x | E15.1% | 0.9% | Media | ||
JNJ | US$149.85 | -0.05% | -6.9% | US$358.5b | US$173.26 | PE21.1x | E6.9% | 3.3% | Pharmaceuticals & Biotech | ||
COST | US$779.04 | 6.4% | 55.2% | US$338.6b | US$777.54 | PE50.9x | E7.5% | 0.6% | Consumer Retailing | ||
600519 | CN¥1,756.00 | 3.0% | 2.3% | CN¥2.2t | CN¥2,161.67 | PE28.3x | E12.7% | 2.8% | Food, Beverage & Tobacco | ||
CVX | US$165.45 | 2.9% | 5.9% | US$299.6b | US$183.11 | PE15x | E2.5% | 3.9% | Energy | ||
NESN | CHF94.20 | 2.6% | -18.2% | CHF246.9b | CHF108.33 | PE22x | E7.1% | 3.2% | Food, Beverage & Tobacco | ||
KO | US$62.88 | 1.4% | -1.5% | US$270.8b | US$67.09 | PE25.1x | E7.7% | 3.1% | Food, Beverage & Tobacco | ||
CRM | US$275.17 | 1.1% | 35.2% | US$270.6b | US$337.07 | PE64.5x | E18.6% | 0.6% | Software | ||
857 | HK$7.34 | 3.4% | 35.4% | HK$1.9t | HK$7.54 | PE7.6x | E-6.0% | 6.5% | Energy | ||
PEP | US$178.06 | 1.5% | -8.8% | US$243.9b | US$187.17 | PE26.7x | E9.4% | 3.0% | Food, Beverage & Tobacco | ||
AZN | UK£123.32 | 1.4% | 3.4% | UK£191.2b | UK£133.20 | PE37.8x | E15.9% | 2.0% | Pharmaceuticals & Biotech | ||
SAP | €177.78 | 5.5% | 45.4% | €206.3b | €186.58 | PE80.1x | E33.2% | 1.2% | Software | ||
WFC | US$61.28 | 2.4% | 59.9% | US$213.5b | US$63.35 | PB1.3x | E3.5% | 2.3% | Banks | ||
INTU | US$626.86 | 2.1% | 47.5% | US$177.1b | US$692.58 | PE63.4x | E17.5% | 0.6% | Software | ||
CAT | US$351.78 | 4.9% | 67.5% | US$168.5b | US$340.98 | PE15.3x | E-2.2% | 1.5% | Capital Goods | ||
AMGN | US$312.86 | 12.4% | 34.7% | US$164.9b | US$313.31 | PE44.6x | E18.2% | 2.9% | Pharmaceuticals & Biotech | ||
IBM | US$166.27 | 1.0% | 37.5% | US$156.1b | US$180.23 | PE18.7x | E5.4% | 4.0% | Software | ||
SIE | €184.08 | 5.1% | 23.7% | €144.3b | €190.83 | PE16.4x | E3.8% | 2.6% | Capital Goods |